Image of the lithium element and metal.
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Wildcat Resources Ltd (ASX:WC8) has reported the potential for lithium oxide (Li2O) grading up to 84% to be recovered through metallurgical testing of ore from its Leia pegmatite – part of the wider Tabba Tabba lithium project in Western Australia.

Flotation testwork on ore from Leia showed recoveries ranging from around 79-84% at head grades of 1.0-1.4% Li2O to produce a 5.5% Li2O concentrate; while there was also the option of 72-84% at head grades of 1.0-1.4% Li2O to produce a 6.0% Li2O concentrate.

The ore was also shown to be low in iron content with no significant deleterious elements, and these recoveries were made using a coarse grind size of 212µm, with this to be modified for future work.

Wildcat is also working towards completion of a pre-feasibility study through activities including expanded metallurgical testing, engineering designs, hydrology and environmental studies, and additional studies during the PFS will aim to optimise and improve recovery.

Managing Director AJ Saverimutto said the company was happy with the indications from initial test work on Leia ore.

“The initial results provide a simple process option, proving that high-grade saleable concentrates can be generated with outstanding spodumene recoveries,” he said.

“We are confident that further metallurgical optimisations leading towards our Pre-Feasibility Study will continue to improve the robustness of Tabba Tabba’s geometallurgical model and favourable project economics.

“We would like to thank BHM Process Consultants and Nagrom for their outstanding work.”

Wildcat has been trading at 27 cents.

wc8 by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…